News

Kamada, a plasma-derived protein therapeutics company focused on orphan indications, announced the appointment of Michal Stein, M.D., as Vice President and Medical Director for…
Read More...

BioCryst Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for a pediatric indication of…
Read More...

Cornerstone Pharmaceuticals announced that it is changing its corporate name to Rafael Pharmaceuticals effective immediately. The name change signifies a new era in the company’s…
Read More...

Aequus Pharmaceuticals and the Centre For Drug Research and Development (CDRD) announced a broad research collaboration to establish pre-clinical safety and efficacy of select…
Read More...

Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for  …
Read More...

The pharmaceutical Company Sylentis (PharmaMar Group) has announced the start of the first Phase III study, HELIX, with the investigational new drug, SYL1001 for the indication of dry…
Read More...

Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma Group have decided to join forces…
Read More...

OBI Pharma announced an agreement with Threshold Pharmaceuticals, Inc. to acquire TH-3424, a first-in-class novel small-molecule prodrug that selectively targets cancers overexpressing…
Read More...

BioCryst Pharmaceuticals announced results from a second interim analysis of its Phase 2 APeX-1 clinical trial in hereditary angioedema (HAE). APeX-1 is a 3-part dose ranging trial…
Read More...

Mylan announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference listed drug, Teva's Azilect Tablets. Mylan received final approval from the…
Read More...

On 3 May 2017, Lonza successfully completed the acquisition of PharmaCell B.V., one of the most-respected cell and gene contract manufacturers in Europe with employees in Maastricht and…
Read More...

Roche announced US Food and Drug Administration (FDA) approval of the VENTANA ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC)…
Read More...

Array BioPharma and Bristol-Myers Squibb Company announced the companies have entered into a clinical research collaboration to investigate the safety, tolerability and efficacy of…
Read More...

Ligand Pharmaceuticals Incorporated announces it will receive $10 million from a contractually specified royalty rate buy-down following the sale by CorMatrix Cardiovascular, Inc. of…
Read More...

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., and Johns Hopkins University announced today that they have extended their drug discovery…
Read More...

Synthetic Genomics and Advaxis announced that they have completed development and deployment of the first current good manufacturing practice (cGMP) synthetic biology facility for the…
Read More...

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide license agreement with Menlo Park, California-based xCella Biosciences, Inc. Under the license, xCella will…
Read More...

New research conducted by scientists at the University of Sheffield into a drug candidate which could help to delay the onset of motor neurone disease has shown encouraging early…
Read More...

AstraZeneca announced that, effective 1 June 2017, the Board has appointed Professor Nazneen Rahman as a Non-Executive Director of AstraZeneca PLC. On appointment, Professor Rahman also…
Read More...

TaiGen Biotechnology has submitted a New Drug Application (NDA) for Taigexyn (Nemonoxacin)intravenous formulation to China Food and Drug Administration (CFDA). Taigexyn is a novel…
Read More...